$0.53 -0.00 (-0.56%) Navidea Biopharmaceuticals Inc - NYSE Amex Equities

Aug. 30, 2016 | 04:00 PM
Last Trade: 0.53
Trade Time: Aug 30 04:00 PM Eastern Daylight Time
Change: +-0.00 (-0.56%)
Prev Close: 0.54
Open: 0.54
Bid: 0.51
Ask: 0.64
  1. No results found.
  1. Lymphoseek® Technically Successful in Evaluation of Sentinel Lymph Node Biopsy in Patients Undergoing Neoadjuvant Chemotherapy

    Benzinga | Dec. 10, 2015 | 16:32PM EST
  2. US Stock Futures Surge; All Eyes On Jobs Report

    Benzinga | Dec. 4, 2015 | 07:11AM EST
  3. Navidea Biopharmaceuticals Announces Positive Lymphoseek Results

    Benzinga | Dec. 4, 2015 | 05:11AM EST
  4. Navidea Biopharmaceuticals Announces Dual Listing on Tel Aviv Stock Exchange

    Benzinga | Sep. 2, 2015 | 07:32AM EST
  5. Macrophage Therapeutics Reports Data Demonstrating a Manocept™ Drug Conjugate Induces Apoptosis in CD206 Positive Kaposi's Sarcoma and Tumor Associated Macrophages

    Benzinga | Jul. 2, 2015 | 07:45AM EST
  6. Navidea Announces Clinical Data for Manocept Shows Agent Localizes in Multiple KS Lesions

    Benzinga | Jul. 2, 2015 | 07:30AM EST
  7. Navidea Announces Manocept Study Results in Rheumatoid Arthritis to be Presented at EULAR '15 ECR

    Benzinga | Jun. 11, 2015 | 07:31AM EST
  8. Navidea Biopharm Enters Agreement With Alseres to Terminate NAV5001 Sub-License Agreement

    Benzinga | Apr. 27, 2015 | 07:32AM EST
  9. European Commission Approves Navidea's Sentinel Lymph Node Detection Agent Lymphoseek

    Benzinga | Nov. 20, 2014 | 07:31AM EST
  10. Navidea Receives $1.1M PDUFA Filing Fee Refund For Award Of Orphan Drug Status; Platinum Partners Reaffirms Commitment To Line Of Credit

    Benzinga | Nov. 11, 2014 | 07:30AM EST
  11. Navidea Joins Essex Woodland's Rheumco, Will Develop Radiopharmaceuticals To Detect And Treat Arthritic Diseases

    Benzinga | Jul. 16, 2014 | 07:32AM EST
  12. UPDATE: Navidea Biopharma Announces Positive Lymphoseek Injection Results

    Benzinga | Jun. 10, 2014 | 16:34PM EST
  13. Navidea Announces Presentation of Study Findings of Manocept Platform Imaging Agent in Kaposi Sarcoma at AACR Annual Meeting

    Benzinga | Apr. 10, 2014 | 07:31AM EST
  14. UPDATE: Navidea Biopharma Offers Update on EMA Application For Lymphoseek, Sets Second sNDA PDUFA Target Date Oct. 16th

    Benzinga | Mar. 19, 2014 | 17:33PM EST
  15. Morning Gainers for Mar. 6, 2014: PXLW, SGMO, ERII, RGSE, NAVB, PSTI

    Benzinga | Mar. 6, 2014 | 11:08AM EST
Trading Center